| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |